Zhejiang Benli Technology Co.,ltd.

Zhejiang Benli Technology Co.,ltd.

浙江本立科技

Zhejiang Benli Technology Co.,ltd.

Biotech/Healthcare

Benli Technology develops and sells pharmaceutical intermediates, primarily quinolone drug intermediates. Its products include ethyl N,N-dimethylaminomethylene acrylate and ethyl 3-(cyclopropylamino)-2-(2,4-dichloro-5-fluorobenzoyl)acrylate, and are sold in markets including India and Japan.

Latest round: Post-IPO (2022)

Source: ChinaBulls — chinabulls.com

Last updated 2022-03-01

Funding history

Request access to view this section.

Investors

Request access to view this section.

HQ & website

Request access to view this section.

Tags

Request access to view this section.